Image Results

Pepcad Balloon Pages on BioPortfolio:

BioPortfolio - Bionostra Group - Profile
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority. Cardiology Today: Nov 16 2009 10:23AM Matching: group ...
http://www.bioportfolio.com/biocorporate/35512-Bionostra+Gro...

BioPortfolio - Cordis - Profile
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority. Endocrine Today: Nov 15 2009 11:45PM Matching: cordis ...
http://www.bioportfolio.com/biocorporate/21291-Cordis.pdf...

BioPortfolio - The AquaMarine Group
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority, Endocrine Today: Nov 15 2009 11:45PM Matching: group ...
http://www.bioportfolio.com/biocorporate/10142-The_AquaMarin...

BioPortfolio - Yardbury Group - Profile
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority. Endocrine Today: Nov 15 2009 11:45PM Matching: group ...
http://www.bioportfolio.com/biocorporate/32172-Yardbury+Grou...

BioPortfolio - Delavau Group
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority, Cardiology Today: Nov 16 2009 10:23AM Matching: group ...
http://www.bioportfolio.com/biocorporate/34611-Delavau_Group...

BioPortfolio - Scientific Group - Profile
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority. Endocrine Today: Nov 15 2009 11:45PM Matching: scientific group ...
http://www.bioportfolio.com/biocorporate/9243-Scientific%252...

BioPortfolio - Zentrale Geschäftsstelle des vdbiol - Profile
PEPCAD-3: Paclitaxel-Coated-Balloon/Stent System Misses Mark in De Novo Coronary Lesions. Medscape: Nov 15 2009 7:00PM Matching: de ...
http://www.bioportfolio.com/biocorporate/31625-Zentrale+Gesc...

BioPortfolio - The Scientific Group
PEPCAD III: Paclitaxel-eluting balloon fails to demonstrate non-inferiority, Endocrine Today: Nov 15 2009 11:45PM Matching: scientific group ...
http://www.bioportfolio.com/biocorporate/9496-The_Scientific...

Results from other life science and pharmaceutical sites:

B. Braun Melsungen AG - Knowledge - Clinical Studies - Current ...
PEPCAD II. The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses: A Comparison to the Paclitaxel-Eluting ...
http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/8648.ht...

Cutting Balloon Angioplasty for Underexpanded Stent: Case Report
Any Delay in Door-to-Balloon Time Associated With Increased in-Hospital Mortality · Post-MI Q Wave an Informative PCI Outcome Marker · PEPCAD-2 ISR ...
http://www.medscape.com/viewarticle/447455_2...

B. Braun Melsungen AG - Press - News
16 Nov 2009 ... PEPCAD III trial investigated a new hybrid drug-eluting balloon/stent system as an alternative to drug-eluting stents ...
http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/news_89...

ESC Barcelona 2009
29 Aug 2009 ... principal investigator of the PEPCAD III study comparing a paclitaxel-eluting balloon with a sirolimus stent. ...
http://www.kerckhoff-klinik.de/Files/downloads/ESC%20Barcelo...

B. Braun Melsungen AG
PEPCAD I and II studies demonstrate the safety and effectiveness of the drug- eluting balloon as an alternative to drug-eluting stents. more ...
http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/2202.ht...

Superficial Femoral Artery Occlusion: Abstract and Introduction
11 Jun 2003 ... Post-MI Q Wave an Informative PCI Outcome Marker · PEPCAD-2 ISR Drug-Coated Balloon Study Now Published · Molecular Signaling in Collateral ...
http://www.medscape.com/viewarticle/453063...

B. Braun Melsungen AG
20 Nov 2009 ... PEPCAD III trial investigated a new hybrid drug-eluting balloon/stent system as an alternative to drug-eluting stents more ...
http://www.bbraun.com/...

Predictors of Restenosis Following Renal Artery Stenting: Methods
Effect of primary balloon expandable renal artery stents on long-term patency, .... PEPCAD-3: Paclitaxel-Coated-Balloon/Stent System Misses Mark in De Novo ...
http://www.medscape.com/viewarticle/467995_2...

Klinische Studien der Kardiologie
26. Nov. 2007 ... Titel der Studie, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Disease to Treat IN-Stent Restenoses. Kurztitel, PEPCAD II ...
http://www.charite.de/kardiologie/KCVK-Studien/details.php?i...

B. Braun Melsungen AG - Press - News
20 Nov 2009 ... PEPCAD III trial investigated a new hybrid drug-eluting balloon/stent system as an alternative to drug-eluting stents more. 2009-10-23 ...
http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/news.ht...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.